Could the Prescription Drug Relief Act Cut Drug Prices in Half?

Image for post
Image for post
Drug Price Cuts Under the Prescription Drug Relief Act of 2019* Premarin, for menopause, which currently costs about $165 for a 30-day supply in the U.S., could cost $83. 
* Januvia, for diabetes, which currently costs about $436 for 30-day supply in the U.S., could cost $218.
* Advair Diskus, for asthma and COPD, which currently costs about $390 for a 30-day supply in the U.S., could cost $195.
* Xarelto, for blood clots, which currently costs about $432 for a 30-day supply in the U.S., could cost $216.
* Lantus, which is insulin for diabetes and currently costs about $387 for a 30-day supply in the U.S., could cost $194.
* Humira, for arthritis, which currently costs about $2,770 for a 30-day supply in the U.S., could cost $1,385.
* Enbrel, for arthritis, which currently costs about $4,941 for a 30-day supply in the U.S., could cost $2,471.
* Ventolin, for asthma, which currently costs about $60 for a 30-day supply in the U.S., could cost $30.
* Xtandi, for cancer, which currently costs about $101 for a 30-day supply in the U.S., could cost $51.
Image for post
Image for post

Tess Francke

MedTruth is a digital magazine reporting on health, safety and justice. Join the revolution today at https://medtruth.com/.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store